<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0401244677
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1994
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        LIDOCAINE HCL 2% INJ 20ML
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LIDOCAINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Ampoule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        80.10
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="B. BRAUN" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            B. BRAUN
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 971]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Medical Supplies And Services Co Ltd (Mediserv)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            B. BRAUN
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N01BB02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr" style="text-align:justify">Lidocaine is a locally and regionally acting anaesthetic.</p><p dir="ltr" style="text-align:justify">It is used to numb a defined body area before a surgical operation.<br />Additionally it may be used to control a severe fast or abnormal heart beat (ventricular tachycardia or tachyarrhythmia). But only if your doctor has assessed your condition as life threatening.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr" style="text-align:justify"><strong>You must not be given Lidocaine HCl 2% inj.</strong></p><ul dir="ltr"><li style="text-align: justify;">&nbsp;If you are allergic to lidocaine or similar substances that are also used as local anaesthetics or any of the other ingredients of this medicine (listed in section 6)</li><li style="text-align: justify;">It must not be used for special techniques in the field of local and regional anaesthesia called epidural or spinal anaesthesia (<strong>1)</strong> if you have<ul><li>Uncorrected blood volume deficit (hypovolemia)</li><li>Compromised blood clotting function (coagulopathy)</li><li>Increased pressure within the skull</li><li>Bleeding within the skull or within the spine.</li></ul></li><li style="text-align: justify;">It must not be used for control of fast or abnormal heart beat if<ul><li>You have severe heart disorders in particular when your heart beats irregularly&nbsp;or beats slowly.</li><li>You experienced a heart attack within the last 3 months.</li><li>The ability of your heart to pump blood throughout your body is markedly decreased unless your condition is life-threatening.</li></ul></li></ul><p dir="ltr" style="margin-left:40px; text-align:justify"><strong>(1)&nbsp;</strong>Epidural or spinal anaesthesia means application of the anaesthetic to the spinal cord.</p><p dir="ltr" style="text-align:justify"><strong>Warnings and precautions</strong><br />Before this medicine is given to you your doctor will make sure that all equipment<br />for the treatment of emergencies and for resuscitation is available.<br />&nbsp;</p><p dir="ltr" style="text-align:justify"><em>Under certain conditions you may receive this medicine only under close medical<br />supervision. Your doctor will take particular caution if you have any of the following conditions:</em></p><ul dir="ltr"><li style="text-align: justify;">Previous allergy to local anaesthetics</li><li style="text-align: justify;">Problems with your heart or your lungs</li><li style="text-align: justify;">Diseases of the liver and kidneys</li><li style="text-align: justify;">A special severe muscle weakness (Myasthenia gravis)</li><li style="text-align: justify;">Severe shock</li><li style="text-align: justify;">Any condition that may lead to an increased risk of fits and seizures (epilepsy)</li></ul><p dir="ltr" style="text-align:justify">Local and regional anaesthesia</p><ul dir="ltr"><li style="text-align: justify;">Your doctor will take into account that especially when you are an elderly patient you may experience low blood pressure as a complication of spinal and epidural anaesthesia (1)</li><li style="text-align: justify;">Additionally your doctor knows that an <u>injection of this medicine into inflamed tissue</u> may lead to an increased uptake of the drug into the circulation and the effect of the drug on your body will be weakened.</li><li style="text-align: justify;"><u>If you are below the age of 30</u> there might be a risk of headache after spinal anaesthesia. Your doctor will use a small needle to reduce this risk.</li><li style="text-align: justify;">Additionally there is <u>a risk of increased side effects when the tourniquet is removed</u> after injection into a vein. Therefore your doctor will drain off this medicine in several portions.</li><li style="text-align: justify;">Your doctor will consider that there is an <u>increased risk of side effects on the nervous system</u> if this medicine is given to your head and neck region.</li></ul><p dir="ltr" style="text-align:justify"><em>Control of fast or abnormal heart beat</em></p><ul dir="ltr"><li style="text-align: justify;">Your doctor will administer this medicine for the treatment of heart problems only with special caution if you have high blood acidity (acidosis).</li><li style="text-align: justify;">&nbsp;If you receive this medicine your<ul><li>Electrocardiogram,</li><li>Blood pressure,</li><li>State of consciousness and</li><li>Breathing will be supervised.</li></ul></li></ul><p dir="ltr" style="text-align:justify">If one of the named parameters is getting worse your doctor may need to revise<br />your therapy.<br />Additionally it will be made sure that during therapy that usual equipment for<br />emergencies is available.</p><ul dir="ltr"><li style="text-align: justify;">If you receive this medicine <u>over a longer period of time </u>your doctor will assure that<ul><li>Your fluid balance,</li><li>Blood salt levels and</li><li>Your acid-base balance will be monitored.</li></ul></li><li style="text-align: justify;">If you receive<u> large amounts</u> of this medicine your doctor will correct<ul><li>Any existing low potassium levels in your blood,</li><li>A deficit of oxygen and</li><li>Disorders of your acid-base balance before start of infusion/injection.</li></ul></li></ul><p dir="ltr" style="text-align:justify"><strong><u>Note:</u></strong><br />If you are under anaesthesia your doctor will examine your condition very carefully. This will be done because side effects affecting your nervous system and your heart may remain unrecognized and can occur without previous warning symptoms.</p><p dir="ltr" style="text-align:justify"><strong>Other medicines and Lidocaine HCl 2% inj.</strong><br />Tell your doctor or pharmacist if you are taking, have recently taken or might take<br />any other medicines.<br />This is necessary as your doctor has to check if the medicines you are taking are<br />metabolized via special enzymes in the body or are influencing their function (Cytochromes P 450 1A2 and 3A4). This is done to avoid interactions between Lidocaine HCl 2% inj. and other medicines you are taking .</p><p dir="ltr" style="text-align:justify">In particular, your doctor will have to know if you are taking any of the following:</p><ul dir="ltr"><li style="text-align: justify;">Some heart medicines, namely special beta blockers (e.g. propranolol) or socalled calcium channel blockers (e.g. amiodarone)</li><li style="text-align: justify;">A ntiarrhythmics - medicines for the treatment of irregular heart beat</li><li style="text-align: justify;">Medicines that narrow your blood vessels (vasoconstrictors,e.g. epinephrine, norepinephrine)</li><li style="text-align: justify;">Cimetidine, a medicine used to treat heartburn</li><li style="text-align: justify;">Antivirals - medicines for the treatment of HIV</li><li style="text-align: justify;">Sleeping pills and medicines that reduce your level of consciousness (sedatives)</li><li style="text-align: justify;">Phenytoin, carbamazepine or primidone that are medicines for the treatment of epilepsy</li><li style="text-align: justify;">Phenobarbital, which is used in general anaesthesia to make you sleep</li><li style="text-align: justify;">Medicines that increase the risk of getting fits and seizures (e.g. tramadol, bupropion)</li><li style="text-align: justify;">The antibiotic erythromycin,</li><li style="text-align: justify;">Anti-psychotics (fluvoxamine), which are used in the treatment of mental illness</li><li style="text-align: justify;">Medicines used to relax muscles in general anaesthesia</li><li style="text-align: justify;">Other anaesthetics.</li></ul><p dir="ltr" style="text-align:justify"><strong>Pregnancy and breast-feeding and fertility</strong><br />Please tell your doctor if you are pregnant or breast-feeding, think you may be<br />pregnant or are planning to have a baby. Then your doctor will decide if you should be given this medicine.</p><p dir="ltr" style="text-align:justify">Pregnancy<br />Your doctor will only administer this medicine while you are pregnant if he/ she<br />considers it as necessary. The dose should be as low as possible.</p><p dir="ltr" style="text-align:justify">Breast-feeding<br />Lidocaine or its metabolites are secreted in small amounts into breast milk. Your<br />doctor will therefore be particularly careful if you are breast feeding. In general,<br />however, at normal doses of this medicine this will not have an effect on your<br />breastfed newborn/infant. So you will not have to discontinue breast feeding.</p><p dir="ltr" style="text-align:justify"><strong>Driving and using machines</strong><br />This medicine may affect your ability to drive or operate machinery depending on<br />where and how it is given to you. Please ask your doctor, especially if areas of your<br />body involved in driving or operating machinery have been under anaesthesia. If<br />your doctor considers it as necessary you should not drive or operate machinery.</p><p dir="ltr" style="text-align:justify"><strong>Lidocaine HCl 2% inj. contains sodium</strong><br />5 ml and 10 ml ampoule:<br />The 5 and 10 ml ampoule of this medicine contain sodium, but less than 23 mg<br />per ampoule. Thus it can be considered as &lsquo;essentially sodium free&rsquo; if you are on a<br />controlled sodium diet.</p><p dir="ltr" style="text-align:justify">20 ml ampoule:<br />This medicine contains 43.7 mg sodium per 20 ml ampoule.<br />Your doctor will take this into consideration if you are on a controlled sodium diet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">This medicine is administered to you by a doctor.<br />You will receive this medicine as an injection into either a vein, the skin, muscle,<br />bone, spine or nerve area.</p><p dir="ltr"><strong>Dosage</strong><br />Your doctor will decide how much medicine you will receive. This depends on your<br />individual situation.</p><p dir="ltr"><em>Use in special patient groups</em><br />In certain groups of people the dose of lidocaine given may need to be reduced<br />depending on for which purpose this medicine is given to you. This includes:</p><ul dir="ltr"><li>Pregnant women</li><li>Babies</li><li>Young children</li><li>Children with high body weight</li><li>The elderly</li><li>People who have a general poor condition</li><li>People with reduced protein binding capacity</li><li>People with kidney impairment</li><li>People with heart and/or liver disease.</li></ul><p dir="ltr"><strong><em>Local and regional anaesthesia</em></strong></p><p dir="ltr"><u>Use in adults</u><br />The normal maximum dosage is 4.5 mg/kg body weight (or 300 mg) . If combined<br />with a suitable medicine that narrows your blood vessels the maximum dosage may<br />be increased up to 7 mg/kg body weight (or 500 mg).</p><p dir="ltr"><u>Use in children and adolescents</u><br />The dose of your child will be calculated individually according to the age, body<br />weight and the nature of the procedure. The maximum dosage for children is 5 mg/kg body weight. If combined with a suitable medicine that narrows your blood vessels the maximum dosage may be increased up to 7 mg/kg body weight.<br />For anaesthesia in children only a low strength of this medicine (0.5%) should be<br />used.</p><p dir="ltr">This medicine has to be used with caution in children younger than 2 years.</p><p dir="ltr"><em>Control of fast or abnormal heart beat</em><br />The dosage must be adjusted according to individual requirements and the therapeutic effect.<br />This especially applies when you are suffering from problems with your heart, liver<br />or kidneys or during pregnancy.</p><p dir="ltr"><strong>If you received more Lidocaine HCl 2% inj. than you should</strong><br />Whether you develop symptoms of an overdose or not depends on the level of this<br />medicine present in your blood. The more lidocaine is in your blood and the more<br />rapidly it is given to you the more frequently and severely you might experience<br />symptoms of an overdosage.</p><p dir="ltr">A small overdose mainly affects your central nervous system. Adverse effects that do occur will disappear in most cases after stopping lidocaine administration.</p><p dir="ltr">Symptoms appearing mainly at the beginning of lidocaine poisoning include:</p><ul dir="ltr"><li>Unpleasant sensations around the mouth</li><li>Feeling of tingling, pricking, or numbness (paraesthesia)</li><li>Unrest, sleepiness, dizziness</li><li>Slurred speech, blurred vision</li><li>Disturbance of vision and hearing, tinnitus</li><li>Muscle twitching, seizures</li><li>Flushing</li><li>High blood pressure</li><li>Fast heartbeat</li><li>Vomiting, feeling sick</li><li>Hallucination, euphoria, anxiety</li><li>Shivering</li></ul><p dir="ltr">The more serious symptoms include</p><ul dir="ltr"><li>Sudden drop of blood pressure</li><li>Paleness of skin</li><li>Impairment or even loss of consciousness (coma)</li><li>Stop of breathing</li><li>Disappearance of pulse</li><li>Heart attack, slow heart beat or irregular heart beat</li><li>Death</li></ul><p dir="ltr">If such severe symptoms appear, your doctor will know how to manage these and<br />give you any necessary treatment.<br />If you have any further questions on the use of this product, ask your doctor or<br />pharmacist.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr" style="text-align:justify">Like all medicines, this medicine can cause side effects, although not everybody<br />gets them.</p><p dir="ltr" style="text-align:justify">The frequency and severity of the side effects of this medicine depend upon the<br />dose, how it is given to you and your individual response to lidocaine.</p><p dir="ltr" style="text-align:justify">Symptoms of local poisoning may occur after you were given this medicine. Side<br />effects related to your whole body may occur at concentrations of lidocaine in the<br />blood exceeding 5-10 mg/l. You might experience symptoms affecting your central nervous system, your circulation and your heart (see also section &lsquo;If you received more Lidocaine HCl 2% inj. than you should&rsquo;).</p><p dir="ltr" style="text-align:justify">Depending on the way you were given this medicine side effects affecting your<br />whole body are more frequently associated when given to you for the control of<br />fast or abnormal heart beat.<br />&nbsp;</p><p dir="ltr" style="text-align:justify"><strong><u>Local and regional anaesthesia</u></strong><br />The following side effects may be serious. If any of the following side effects occur, please tell your doctor immediately. Immediate treatment might be needed:</p><p dir="ltr" style="text-align:justify"><u>Rare (may affect up to 1 in 1 000 people):</u></p><ul dir="ltr"><li style="text-align: justify;">Allergic reactions ranging from rashes and swelling to severe allergic reactions such as drop of blood pressure, difficulty breathing, constriction of airways and shock.</li><li style="text-align: justify;">Compression of the spinal cord due to the development of bruise</li><li style="text-align: justify;">Partial or complete paralysis</li><li style="text-align: justify;">Numbness or paralysis in limbs that do not resolve</li><li style="text-align: justify;">Cauda equina syndrome: compression of a special kind of nerve roots manifesting in the form of weakness of the muscles of the lower extremities, loss of control over passing stools and urine and loss of sensation in the area of the buttocks</li><li style="text-align: justify;">Lesions of your brain nerves</li></ul><p dir="ltr" style="text-align:justify"><strong><em>Other side effects include</em></strong><br /><u>Very common (may affect more than 1 in 10 people):</u></p><ul dir="ltr"><li style="text-align: justify;">Feeling sick, vomiting</li></ul><p dir="ltr" style="text-align:justify"><u>Common (may affect up to 1 in 10 people):</u></p><ul dir="ltr"><li style="text-align: justify;">&bull; pain in legs and lower back after epidural or spinal anaesthesia. The pain may last up to 5 days and will resolve without further treatment</li></ul><p dir="ltr" style="text-align:justify"><u>Rare (may affect up to 1 in 1 000 people):</u></p><ul><li dir="ltr" style="text-align: justify;">Sensation of tickling, tingling, burning, pricking, or numbness</li><li dir="ltr" style="text-align: justify;">Headaches accompanied by sensitivity to sunlight (photophobia) and hearing (tinnitus)</li><li dir="ltr" style="text-align: justify;">An affection of eyelids, eye muscles and iris, called Horner&rsquo;s syndrome. It occursafter epidural anaesthesia or application in the head/neck region</li><li dir="ltr" style="text-align: justify;">Shivering, deafness, or trauma</li><li dir="ltr" style="text-align: justify;">Transient irritation of the nerve roots due to spinal anaesthesia.</li><li style="text-align: justify;">&nbsp;</li></ul><p dir="ltr" style="text-align:justify"><strong><u>Control of fast or abnormal heart beat</u></strong><br />The following side effects may be serious. If any of the following side effects occur, please tell your doctor immediately. Immediate treatment might be needed:</p><p dir="ltr" style="text-align:justify"><u>Rare (may affect up to 1 in 1 000 people):</u></p><ul dir="ltr"><li style="text-align: justify;">Allergic reactions ranging from rashes and swelling to severe allergic reactions such as drop of blood pressure, difficulty breathing, constriction of airways and shock</li><li style="text-align: justify;">Muscular twitching up to generalized fits and seizures,</li><li style="text-align: justify;">Depressed level of consciousness up to coma</li><li style="text-align: justify;">Slow heart beat, heart block up to hear arrest</li><li style="text-align: justify;">Low blood pressure</li><li style="text-align: justify;">Difficulties in breathing up to stop of breathing</li></ul><p dir="ltr" style="text-align:justify"><u>Very rare (may affect up to 1 in 10 000 people):</u></p><ul dir="ltr"><li style="text-align: justify;">Fast heart beat</li></ul><p dir="ltr" style="text-align:justify"><strong><u>Other side effects include</u></strong><br />Very common (may affect more than 1 in 10 people):</p><ul dir="ltr"><li style="text-align: justify;">Feeling sick, vomiting</li><li style="text-align: justify;">Anxiety, difficulties in swallowing</li></ul><p dir="ltr" style="text-align:justify"><u>Common (may affect up to 1 in 10 people):</u></p><ul dir="ltr"><li style="text-align: justify;">Confusion, restlessness, irritability, euphoria, hallucinations, depression</li><li style="text-align: justify;">Sleepiness, dizziness, feeling of spinning, slurred speech, tinnitus, blurred vision</li><li style="text-align: justify;">Sensation of tickling, tingling, burning, pricking, or numbness of the skin</li></ul><p dir="ltr" style="text-align:justify"><u><em>Elderly patients</em></u><br />Elderly patients may be more prone to some of the effects mentioned above.</p><p dir="ltr" style="text-align:justify"><u><em>Children</em></u><br />Frequency, type and severity of side effects in children are expected to be the same as in adults.</p><p dir="ltr" style="text-align:justify"><strong>To report any side effects:<br />National Pharmacovigilance &amp; Drug Safety Center (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340<br />Toll free phone : 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not store above 25 &deg;C.</p><p>Do not use this medicine after the expiry date, which is stated on the ampoule and<br />the outer carton after &ldquo;EXP&rdquo;. The expiry date refers to the last day of that month.</p><p>Containers are for single use only. Unused contents of containers once opened must be discarded.</p><p>Solution is to be administered immediately after opening the container.</p><p>The solution is only to be used if the solution is clear and colourless and the container and its closure are undamaged.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul dir="ltr"><li>The active substance is lidocaine hydrochloride.</li></ul><p dir="ltr">One ml of the solution for injection contains 20 mg of lidocaine hydrochloride monohydrate.</p><p dir="ltr">One ampoule of 5 ml contains 100 mg of lidocaine hydrochloride monohydrate.</p><p dir="ltr">One ampoule of 10 ml contains 200 mg of lidocaine hydrochloride monohydrate.</p><p dir="ltr">One ampoule of 20 ml contains 400 mg of lidocaine hydrochloride monohydrate.</p><ul dir="ltr"><li>The other ingredients are</li></ul><p dir="ltr">sodium chloride, sodium hydroxide and water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Lidocaine HCl 2% inj. is a solution for injection.
It is a clear colourless solution of the aforementioned ingredients in water.
It comes in polyethylene plastic ampoules holding 5 ml, 10 ml or 20 ml.
It is supplied in packs of 20 ampoules of each size or 5 x 20 x 5ml.
It is also available in glass ampoules made of colourless glass holding 5 ml.
It is supplied in packs of 10 ampoules of 5 ml.

Not all pack-sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>B. Braun Melsungen AG<br />Carl-Braun-Str 1&nbsp;<br />34212 Melsungen, Germany&nbsp;</p><p><em>Postal address</em><br />34209 Melsungen, Germany</p><p>Phone: +49-5661-71-0<br />Fax: +49-5661-71-4567</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                09/2012
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p style="text-align:justify">الليدوكائين هو مخدر موضعي وناحي، ويستخدم لتخدير منطقة محددة من الجسم قبل إجراء عملية جراحية.<br />وبالإضافة إلى ذلك، يمكن استخدامه للتحكم في ضربات القلب الشديدة السرعة أو غير الطبيعية (&nbsp;تسرع القلب البطيني أو اضطراب النَظْم التسرّعي). لكن ذلك لا يتم إلا إذا كان طبيبك قد قام بتقييم حالتك وقرر أنها مهدّدة للحياة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:justify"><strong>لا يجب أن يوصف لك Lidocaine HCl 2% inj. </strong></p><p style="text-align:justify">&nbsp;</p><ul><li dir="rtl" style="text-align: justify;">&nbsp;إذا كنت تعاني من حساسية لليدوكائين أو المواد المشابهة التي تستخدم أيضا في التخدير الموضعي أو أي من المكونات الأخرى من هذا الدواء (المذكورة في الفقرة 6)</li><li dir="rtl" style="text-align: justify;">&nbsp;يجب ألا يستخدم لإجراء التقنيتين الخاصتين في مجال التخدير الموضعي والناحي، والمعروفتين باسم التخدير فوق الجافية أو التخدير الشوكي (1) إذا كنت تعاني من أي من الحالات التالية:<ul><li>- نقص غير مصحّح في حجم الدم ( نقص حجم الدم)</li><li>- اضطراب وظيفة تخثّر الدم (&nbsp;اعتلال تخّثري )</li><li>- زيادة الضغط داخل الجمجمة</li><li>- نزيف داخل الجمجمة أو داخل العمود الفقري.</li></ul></li><li dir="rtl" style="text-align: justify;">لا يجب استخدامه من أجل التحكم في ضربات القلب السريعة أو غير الطبيعية في الحالات التالية:<ul><li>- إذا كنت مصابا باضطرابات قلبية حادة، وخصوصا عندما تكون ضربات قلبك غير منتظمة، أو بطيئة</li><li>- إذا أصبت بنوبة قلبية خلال الثلاثة أشهر الماضية</li><li>- إذا انخفضت قدرة قلبك بشكل ملحوظ على ضخ الدم إلى جميع أجزاء الجسم، إلا إذا كانت حالتك مهددة للحياة.</li></ul></li></ul><p style="text-align:justify"><strong>التحذيرات والاحتياطات</strong></p><p style="text-align:justify">قبل إعطاء هذا الدواء لك، سيقوم طبيبك بالتأكد من توافر جميع المعدات اللازمة لعلاج حالات الطوارئ وإجراء عمليات الإنعاش.</p><p style="text-align:justify">في ظل ظروف معينة، لا يمكنك تل قي هذا الدواء إلا تحت إشراف طبي دقيق. سيقوم طبيبك بأخذ احتياطات خاصة إذا كنت مصاباً بأي من الحالات التالية:</p><ul><li style="text-align: justify;">حساسية سابقة لأدوية التخدير الموضعي&nbsp;</li><li style="text-align: justify;">مشكلات في قلبك أو رئتيك&nbsp;</li><li style="text-align: justify;">أمراض الكبد والكلى&nbsp;</li><li style="text-align: justify;">وجود ضعف خاص شديد في العضلات ( الوهن العضلي الوبيل)&nbsp;</li><li style="text-align: justify;">الصدمة الشديدة&nbsp;</li><li style="text-align: justify;">أية حالة قد تؤدي إلى زيادة خطر التشنجات ا ولاختلاجات (الصرع)&nbsp;</li></ul><p style="text-align:justify">&nbsp;</p><p style="text-align:justify">التخدير الموضعي والناحي</p><ul><li style="text-align: justify;" dir="rtl">سوف يضع طبيبك في اعتباره، وخصوصا إذا كنت <u>مريضا مسن</u>&nbsp;أنك قد تواجه انخفاضا في ضغط الدم نتيجة لحدوث&nbsp;مضاعفات التخدير الشوكي أو التخدير فوق الجافية (عني التخدير فوق الجافية أو التخدير الشوكي تطبيق مخدر على الحبل الشوكي).</li><li style="text-align: justify;" dir="rtl">وبالإضافة إلى ذلك، فإن الطبيب يعرف أن <u>حقن هذا الدواء في الأنسجة الملتهبة</u> قد يؤدي إلى زيادة امتصاص الدواء إلى الدورة&nbsp;الدموية، ومن ثم فإن تأثير الدواء على جسمك سوف يضعف.</li><li style="text-align: justify;" dir="rtl">إ<u>ذا كنت دون سن الثلاثين</u>، فقد يكون هناك خطر للإصابة بالصداع بعد التخدير الشوكي. سيقوم طبيبك باستخدام إبرة&nbsp;صغيرة لتقليل هذه المخاطر.</li><li style="text-align: justify;" dir="rtl">وبالإضافة إلى ذلك، هناك <u>خطر لزيادة الآثار الجانبية عند إزالة العاصبة</u> بعد الحقن في الوريد. ولذلك فإن الطبيب سيقوم بنزح&nbsp;هذا الدواء على عدة أجزاء.</li><li style="text-align: justify;" dir="rtl">سيعتبر طبيبك أن هناك <u>خطر متزايد لحدوث الآثار الجانبية في الجهاز العصبي</u> إذا تم إعطاء هذا الدواء في منطقة الرأس والرقبة.&nbsp;</li></ul><p style="text-align:justify">التحكم في ضربات القلب السريعة أو غير الطبيعية</p><ul><li style="text-align: justify;" dir="rtl">لن يقوم طبيبك باستخدام هذا الدواء لعلاج المشكلات القلبية إلا بموجب احتياطات خاصة إذا كنت مصابا بزيادة في حموضة الدم (الحماض ).</li><li style="text-align: justify;" dir="rtl">إذا كنت تتلقى هذا الدواء، فستتم مراقبة كل من&nbsp;<ul><li style="text-align: justify;">- تخطيط كهربية القلب،</li><li style="text-align: justify;">- ضغط الدم،</li><li style="text-align: justify;">- حالة الوعي و</li><li style="text-align: justify;">- التنفس.</li></ul></li></ul><p style="text-align:justify">إذا ازداد أحد هذه المعايير المذكورة سوءا، فقد يحتاج طبيبك إلى مراجعة علاجك.</p><p style="text-align:justify">وبالإضافة إلى ذلك، سيتم التأكد أثناء العلاج من توافر المعدات اللازمة لعلاج حالات الطوارئ.</p><ul><li style="text-align: justify;" dir="rtl">إذا كنت تتلقى هذا الدواء <u>على مدى فترة طويلة من الزمن</u> فسيقوم طبيبك بالتأكد من مراقبة ما يلي في جسمك:&nbsp;<ul><li style="text-align: justify;">- توازن السوائل،</li><li style="text-align: justify;">- مستويات الملح في الدم و</li><li style="text-align: justify;">- التوازن الحمضي القاعدي.</li></ul></li><li style="text-align: justify;" dir="rtl">إذا كنت تتلقى <u>كميات كبيرة</u> من هذا الدواء، فسيقوم طبيبك بتصحيح:&nbsp;<ul><li style="text-align: justify;">- أي انخفاض في مستويات البوتاسيوم في دمك،</li><li style="text-align: justify;">- نقص الأكسجين و</li><li style="text-align: justify;">- اضطرابات التوازن الحمضي القاعدي قبل بدء التسريب/ الحقن.</li></ul></li></ul><p style="text-align:justify">ملاحظة:</p><p style="text-align:justify">إذا كنت تحت التخدير، سيدرس الطبيب حالتك بعناية فائقة. وسيتم ذلك لأن الآثار الجانبية التي تؤثر على جها زك العصبي وقلبك قد لا تظهر، كما يمكن أن تحدث دون أعراض تحذيرية.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>. تفاعلات الأدوية الأخرى مع Lidocaine HCl 2% inj</strong></p><p style="text-align:justify">أخبر طبيبك أو الصيدلي إذا كنت تتناول، أو تناولت مؤخرا أو قد تتناول أية أدوية أخرى.</p><p style="text-align:justify">وهذا أمر ضروري لأن الطبيب يجب أن يتحقق مما إذا كانت الأدوية التي تتناولها تسُتقلب عن طريق إنزيمات خاصة في الجسم أو تأثر على&nbsp;وظيفتها (السيتوكرومات3A4 P450 1A2 ) ويتم ذلك لتجنب حدوث تفاعلات دوائية بين Lidocaine&nbsp;HCl 2% inj&nbsp;والأدوية الأخرى التي تتناولها. .</p><p style="text-align:justify">وبصفة خاصة، يتوجب على طبيبك أن يعرف إذا كنت تتناول أيا مما يلي:</p><ul><li style="text-align: justify;">بعض الأدوية القلبية، وبالتحديد بعض مُحصرات بيتا الخاصة (مثل البروبرانولول ) أو ما يسمى مُحصرات قنوات الكالسيوم (مثل&nbsp;الأميودارون )</li><li style="text-align: justify;">مضادات اضطراب نَظْم القلب- وهي أدوية تستخدم لعلاج عدم انتظام ضربات القلب&nbsp;</li><li style="text-align: justify;">الأدوية التي تضي ق الأوعية الدموية ( مضيّقات الأوعية، مثل الأدرينالين، والنور أدرينالين )&nbsp;</li><li style="text-align: justify;">السيميتيدين، وهو دواء يستخدم لعلاج حرقة الفؤاد&nbsp;</li><li style="text-align: justify;">الأدوية المضادة للفيروسات- وهي أدوية تستخدم لعلاج فيروس العوز المناعي البشري&nbsp;</li><li style="text-align: justify;">الحبوب المنومة والأدوية التي تقلل مستوى الوعي (المهدئات)&nbsp;</li><li style="text-align: justify;">الفينيتوين، أو الكاربامازيبين أو البريميدون؛ وهي أدوية لعلاج الصرع&nbsp;</li><li style="text-align: justify;">الفينوباربيتال، والذي يستخدم في التخدير العام لتجعلك تنام&nbsp;</li><li style="text-align: justify;">الأدوية التي تزيد من خطر الإصابة بالتشنجات والاختلاجات (مثل الترامادول، والبوبروبيون )&nbsp;</li><li style="text-align: justify;">الإريثروميسين، وهو أحد المضادات الحيوية&nbsp;</li><li style="text-align: justify;">مضادات الذ هان ( فلوفوكسامين )، والتي تستخدم في علاج الأمراض النفسية&nbsp;</li><li style="text-align: justify;">الأدوية المستخدمة لإ رخاء العضلات أثناء التخدير العام&nbsp;</li><li style="text-align: justify;">أدوية التخدير الأخرى.&nbsp;</li></ul><p style="text-align:justify">ا<strong>لحمل و الرضاعة الطبيعية والخصوبة</strong></p><p style="text-align:justify">يرجى إخبار الطبيب إذا كنت حاملا أو ترضعين طفلك طبيعيا، أو تظنين أنك قد تكونين حاملا أو تخططين لإنجاب طفل، وعندها سيقرر الطبيب ما إذا كان يجب إعطاءك هذا الدواء.</p><p style="text-align:justify"><strong>الحمل</strong></p><p style="text-align:justify">لن يقوم طبيبك بإعطائك هذا الدواء أثناء الحمل إلا إذا اعتبر ذلك ضروريا. ويجب أن تكون جرعة منخفضة قدر الإمكان.</p><p style="text-align:justify">ا<strong>لرضاعة الطبيعية</strong></p><p style="text-align:justify">يفُرز الليدوكائين أو عناصره بكميات صغيرة في حليب الأم، ولذلك فإن طبيبك سيتوخى الحذر بصفة خاصة إذا كنت ترضعين طفلك طبيعيا. وبشكل عام، على أية حال، فعند إعطاء هذا الدواء بجرعات عادية، فلن يكون لها تأثير على الرضاعة الطبيعية لأطفالك الحديثي الولادة/ الر ضع. وبالتالي فلن تضط يرن إلى وقف الرضاعة الطبيعية.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>القيادة واستخدام الآليات</strong></p><p style="text-align:justify">قد يؤثر هذا الدواء على قدرتك على القيادة أو تشغيل الآلات اعتمادا على أين وكيف يتم إعطاؤه لك. يرجى أن تطلب من الطبيب، خصوصا إذا كانت أجزاء جسمك المستخدمة في قيادة السيا ارت أو تشغيل الآلات واقعة تحت التخدير. إذا كان طبيبك يعتبر ذلك ضروريا، فعليك أن تمتنع عن قيادة السيارات وتشغيل الآلات.</p><p style="text-align:justify"><strong>يحتوي Lidocaine HCl 2% inj على الصوديوم.</strong></p><p style="text-align:justify">الأمبولة عبوة&nbsp;5 مل و 10 مل:</p><p style="text-align:justify">إن الأمبولة عبوة&nbsp;5 مل و 10 مل من هذا الدواء تحتوي على الصوديوم، ولكن بكمية أقل من 23 ملغ لكل أمبولة. وبالتالي فإنه يمكن اعتبارها &quot;خالية من الصوديوم جوهريا&quot; إذا كنت تتبع حمية غذائية محدودة الصوديوم.</p><p style="text-align:justify">الأمبولة عبوة&nbsp;20 مل:</p><p style="text-align:justify">يحتوي هذا الدواء على 43.7 ملغ من الصوديوم لكل أمبولة عبوة 20 مل.</p><p style="text-align:justify">سوف يأخذ طبيبك ذلك في الاعتبار إذا كنت تتبع حمية غذائية محدودة الصوديوم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:justify">يتم إعطاؤك هذا الدواء من قبل طبيب.<br />سوف تتلقى هذا الدواء عن طريق الحقن إما في الوريد ، أو في الجلد أو العضلات أو العظام أو العمود الفقري أو منطقة عصبية.</p><p style="text-align:justify"><strong>الجرعة</strong><br />سوف يقرر طبيبك الجرعة التي ستتلقاها من الدواء. يعتمد هذا على حالتك الفردية.</p><p style="text-align:justify">الاستخدام في مجموعات خاصة من المرضى</p><p style="text-align:justify">في مجموعات معينة من الأشخاص، قد يلزم تقليل جرعة الليدوكائين وفقا لغرض إعطائك هذا الدواء. ويشمل هذا ما يلي:</p><ul><li dir="rtl" style="text-align: justify;">النسوة الحوامل&nbsp;</li><li dir="rtl" style="text-align: justify;">الرضّع&nbsp;</li><li dir="rtl" style="text-align: justify;">الأطفال الصغار&nbsp;</li><li dir="rtl" style="text-align: justify;">الأطفال ذوي وزن الجسم الزائد&nbsp;</li><li dir="rtl" style="text-align: justify;">المسن ون&nbsp;</li><li dir="rtl" style="text-align: justify;">الأشخاص ذوي الحالة العامة السيئة&nbsp;</li><li dir="rtl" style="text-align: justify;">الأشخاص ذوي القدرة المنخفضة على ربط البروتينات&nbsp;</li><li dir="rtl" style="text-align: justify;">الأشخاص المصابون بتعطل وظائف الكلى&nbsp;</li><li dir="rtl" style="text-align: justify;">الأشخاص المصابون بأمراض القلب و/ أو الكبد.&nbsp;</li></ul><p style="text-align:justify"><strong>التخدير الموضعي والناحي</strong><br />ا<u>لاستخدام في البالغين</u><br />الحد الأقصى للجرعة العادية هو 4.5 ملغ/ كغم من وزن الجسم ( أو 300 ملغ). وإذا ترافق إعطاؤه مع دواء مناسب مضيّق للأوعية الدموية، فيمكن زيادة الحد الأقصى للجرعة إلى 7 ملغ/ كغم من وزن الجسم ( أو 500 ملغ).</p><p style="text-align:justify">ا<u>لاستخدام في الأطفال والمراهقين</u><br />سيتم احتساب الجرعة لطفلك بشكل فردي وفقا لعمر ووزن الجسم وطبيعة الإجراء. تبلغ الجرعة القصوى للأطفال 5 ملغ/ كغم من وزن الجسم. وإذا ترافق إعطاؤه مع دواء مناسب مضيّق للأوعية الدموية، فيمكن زيادة الحد الأقصى للجرعة إلى 7 ملغ/ كغم<br />من وزن الجسم.<br />بالنسبة للتخدير في الأطفال، يجب ألا يستخدم إلا تركيز منخفض من هذا الدواء (0.5%)</p><p style="text-align:justify">لابد من استخدام هذا الدواء بحذر في الأطفال الذين تقل أعمارهم عن السنتين.</p><p style="text-align:justify"><u>التحكم في ضربات القلب السريعة أو غير الطبيعية</u><br />يجب أن يتم ضبط الجرعة وفقا لمتطلبات الفرد ا ولتأثير العلاجي.<br />وينطبق هذا بشكل خاص إذا كنت تعاني من مشكلات في القلب أو الكبد أو الكلى أو أثناء الحمل.</p><p style="text-align:justify"><strong>إذا تلقيت جرعة أكبر مما يجب من Lidocaine HCl 2% inj. </strong></p><p style="text-align:justify">إن إصابتك بأعراض الجرعة الزائدة أو عدمه لا يعتمد على مستوى وجود هذا الدواء في الدم. كلما ازدادت كمية الليدوكائين في دمك كلوما ازدادت سرعة إعطاؤه لك، سيزداد تواتر وشدة أعراض الجرعة الزائدة التي قد تواجهها.</p><p style="text-align:justify">تؤثر الجرعة الزائدة الصغيرة بشكل رئيسي على الجهاز العصبي المركزي. إن الآثار الجانبية التي تحدث سوف تختفي في معظم الحالات بعد إيقاف إعطاء الليدوكائين.</p><p style="text-align:justify">تشمل الأعراض التي تظهر بشكل رئيسي في بداية التسمم بالليدوكائين ما يلي:</p><ul><li style="text-align: justify;" dir="rtl">أحاسيس بغيضة حول الفم&nbsp;</li><li style="text-align: justify;" dir="rtl">الشعور بالوخز، أو النَخز، أو الخدر ( المذل)&nbsp;</li><li style="text-align: justify;" dir="rtl">الاضطراب، والنعاس، والدوخة&nbsp;</li><li style="text-align: justify;" dir="rtl">صعوبة النطق، وتغيّم الرؤية&nbsp;</li><li style="text-align: justify;" dir="rtl">اضطراب الرؤية والسمع، وطنين الأذن&nbsp;</li><li style="text-align: justify;" dir="rtl">ارتعاش العضلات، والاختلاجات&nbsp;</li><li style="text-align: justify;" dir="rtl">البيغ&nbsp;</li><li style="text-align: justify;" dir="rtl">ارتفاع ضغط الدم&nbsp;</li><li style="text-align: justify;" dir="rtl">سرعة ضربات القلب&nbsp;</li><li style="text-align: justify;" dir="rtl">القيء، الشعور بالغثيان&nbsp;</li><li style="text-align: justify;" dir="rtl">الهلوسة، والنشوة، والقلق&nbsp;</li><li style="text-align: justify;" dir="rtl">الارتجاف&nbsp;</li></ul><p style="text-align:justify">تشمل الأعراض الأكثر خطورة ما يلي</p><ul><li style="text-align: justify;" dir="rtl">انخفاض مفاجئ في ضغط الدم&nbsp;</li><li style="text-align: justify;" dir="rtl">شحوب الجلد&nbsp;</li><li style="text-align: justify;" dir="rtl">ضعف أو حتى فقدان الوعي ( الغيبوبة )&nbsp;</li><li style="text-align: justify;" dir="rtl">توقف التنفس&nbsp;</li><li style="text-align: justify;" dir="rtl">اختفاء النبض&nbsp;</li><li style="text-align: justify;" dir="rtl">نوبة قلبية، وبطء ضربات القلب أو عدم انتظام ضربات القلب&nbsp;</li><li style="text-align: justify;" dir="rtl">الموت&nbsp;</li></ul><p style="text-align:justify">في حالة ظهور مثل هذه الأعراض الشديدة، سيعرف طبيبك كيفية تدبيرها وسيعطيك أي علاج لازم.</p><p style="text-align:justify">إذا كانت لديك أية أسئلة أخرى حول استخدام هذا المنتج، استشر طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن لهذا الدواء أن يسبب آثارا جانبية، وإن لم يكن الجميع يتعرضون لذلك.</p><p>يعتمد تواتر وشدة الآثار الجانبية لهذا الدواء على الجرعة، وطريقة إعطاؤه لك واستجابتكم الفردية لليدوكائين.</p><p>قد تحدث أعراض التسمم الموضعي بعد أن يُعطى لك هذا الدواء. أما الآثار الجانبية المتعلقة بالجسم كله فقد تحدث عندما تزيد تركيزات الليدوكائين في الدم عن 5- 10 ملغم/ لتر. قد تواجه أعراضا تصيب جها زك العصبي المركزي، أو دورتك الدموية، أو/&nbsp;و قلبك (انظر أيضا فقرة &#39; إذا كنت قد تلقيت جرعة أكبر مما يجب من Lidocaine Hcl 2%inj)<br />بناء على طريقة إعطائك هذا الدواء، فإن الآثار الجانبية التي تؤثر على الجسم كله تكون أكثر تواترا عندما يعُطى لك من أجل التحكم في ضربات القلب السريعة أو غير الطبيعية.</p><p>ا<strong>لتخدير الموضعي والناحي</strong><br />قد تكون الآثار الجانبية التالية خطيرة. إذا حدث أي من الآثار الجانبية التالية، يرجى إبلاغ الطبيب فورا. قد تكون هناك حاجة إلى علاج فوري:</p><p><u>نادرة (قد تصيب ما يصل إلى 1 من بين كل ألف شخص):</u></p><ul><li dir="rtl">استجابات أرجية تتراوح بين الطفح الجلدي والتورم وبين استجابات أرجية شديدة مثل انخفاض ضغط الدم وصعوبة التنفس،&nbsp;&nbsp;ونقباض الشعب الهوائية والصدمة</li><li dir="rtl">انضغاط الحبل الشوكي نتيجة لحدوث كدمة&nbsp;</li><li dir="rtl">شلل جزئي أو كامل&nbsp;</li><li dir="rtl">خدر أو شلل في الأطراف، ا ولذي لا ينصرف من تلقاء نفسه&nbsp;</li><li dir="rtl">متلازمة ذيل الفرس: انضغاط نوع خاص من الجذور العصبية، والذي يظهر على شكل ضعف في عضلات الط فرين السفليين،&nbsp;وفقدان التحكم في إخراج البول ا ولبراز، وفقدان الإحساس في منطقة الردفين</li><li dir="rtl">آفات الأعصاب الدماغية&nbsp;</li></ul><p>تشمل الآثار الجانبية الأخرى ما يلي:</p><p><u>شائعة للغاية (قد تصيب أكثر من 1 من بين كل 10 أشخاص):</u></p><ul><li dir="rtl">الشعور بالغثيان والقيء&nbsp;</li></ul><p><u>شائعة (قد تصيب ما يصل إلى 1 من بين كل 10 أشخاص):</u></p><ul><li dir="rtl">ألم في الساقين و أسفل الظهر بعد التخدير فوق الجافية أو التخذير الشوكي. قد يستمر الألم لمدة تصل إلى 5 أيام، لكنه سينصرف من تلقاء نفسه دون مزيد من العلاج</li></ul><p><u>نادرة (قد تصيب ما يصل إلى 1 من بين كل ألف شخص):</u></p><ul><li dir="rtl">إحساس بالدغدغة، أو الوخز، أو الحرق، أو النخز، أو الخدر&nbsp;</li><li dir="rtl">صداع يرافقه تحسّس لأشعة الشمس ( رُهاب الضوء ) والسمع ( الطنين )&nbsp;</li><li dir="rtl">إصابة الجفون، عضلات العين والقزحية، بحالة تسمى متلازمة هورنر. وتحدث بعد التخدير فوق الجافية أو تطبيق الدواء في منطقة الرأس/ العنق</li><li dir="rtl">الارتجاف، أو الصمم، أو الصدمة&nbsp;</li><li dir="rtl">ييج عابر لجذور الأعصاب بسبب التخدير الشوكي.&nbsp;</li></ul><p><u><strong>التحكم في ضربات القلب السريعة أو غير الطبيعية</strong></u></p><p>قد تكون الآثار الجانبية التالية خطيرة. إذا حدث أي من الآثار الجانبية التالية، يرجى إبلاغ الطبيب فورا. قد تكون هناك حاجة إلى علاج فوري:</p><p><u>نادرة (قد تصيب ما يصل إلى 1 من بين كل ألف شخص):</u></p><ul><li dir="rtl">استجابات أرجية تتراوح بين الطفح الجلدي والتورم وبين استجابات أرجية شديدة مثل انخفاض ضغط الدم وصعوبة التنفس،&nbsp;وانقباض الشعب الهوائية والصدمة</li><li dir="rtl">ارتجاف عضلي قد يصل إلى نوبات معممة واختلاجات،&nbsp;</li><li dir="rtl">انخفاض مستوى الوعي، والذي قد يصل إلى الغيبوبة&nbsp;</li><li dir="rtl">بطء ضربات القلب، وإحصار القلب الذي قد يصل إلى توقف القلب&nbsp;</li><li dir="rtl">انخفاض ضغط الدم&nbsp;</li><li dir="rtl">صعوبات في التنفس، والتي قد تصل إلى توقف التنفس&nbsp;</li></ul><p><u>ناد ةر للغاية (قد تصيب ما يصل إلى 1 من بين كل 10000 شخص):</u></p><ul><li dir="rtl">تسارع ضربات القلب&nbsp;</li></ul><p>&nbsp;</p><p>تشمل الآثار الجانبية الأخرى ما يلي</p><p><u>شائعة للغاية (قد تصيب أكثر من 1 من بين كل 10 أشخاص):</u></p><ul><li dir="rtl">الشعور بالغثيان والقيء ●</li><li dir="rtl">القلق، وصعوبات في البلع ●</li></ul><p><u>شائعة (قد تصيب ما يصل إلى 1 من بين كل 10 أشخاص):</u></p><ul><li dir="rtl">الالتباس، والأرق، والتهيج، والنشوة، ا ولهلوسة، والاكتئاب&nbsp;</li><li dir="rtl">النعاس، والدوخة، والشعور بالدوار وثقل اللسان، ا ولطنين، وتغيّم الرؤية&nbsp;</li><li dir="rtl">إحساس بالدغدغة، أو الوخز، أو الحرق، أو النخز، أو الخدر&nbsp;</li></ul><p>المرضى المسنون<br />قد يكون المرضى المسنين أكثر عرضة لبعض الآثار المذكورة أعلاه.</p><p>الأطفال<br />من المتوقع أن يكون تواتر، نوع وشدة الآثار الجانبية في الأطفال هي نفسها لدى البالغين.</p><p><strong>للإبلاغ عن أية آثار جانبية:<br />المركز الوطني للتيقظ والسلامة الدوائية<br />فاكس: 7662-205-11-966+<br />هاتف: 8222-203-11-966+</strong></p><p><strong>تحويلة: 2317-2356-2353-2354-2334-2340<br />&bull; الرقم المجاني: 8002490000<br />&bull; البريد الإلكتروني: npc.drug@sfda.gov.sa&nbsp;<br />الموقع الإلكتروني: www.sfda.gov.sa/npc&nbsp;</strong><br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>احفظ هذا الدواء بعيدا عن مرأى ومتناول الأطفال.</p><p>لا تحفظه في درجة حرارة أعلى من 25 درجة مئوية.</p><p>لا تستعمل هذا الدواء بعد انتهاء فترة الصلاحية المذكورة على الأمبولة او الكرتونة الخارجية بعد كلمة EXP يشير تاريخ انتهاء .</p><p>الصلاحية إلى آخر يوم من ذلك الشهر.</p><p>العبوة الزجاجية هي للاستخدام مرة واحدة فقط. يجب التخلص من العبوة مع أي جزء غير مستخدم من محتوياتها&nbsp;بعد فتحها.&nbsp;</p><p>يجب إعطاء المحلول بعد فتح الحاوية مباشرة.</p><p>لا يُستخدم المحلول إلا إذا كان المحلول صافيا وعديم اللون والعبوة وتغليفها سليم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي هيدروكلوريد الليدوكائين.&nbsp;</p><ul><li dir="rtl">يحتوي واحد مل من المحلول المخصص للحقن على 20 ملغ من هيدروكلوريد مونوهيدرات الليدوكائين.</li><li dir="rtl">تحتوي أمبولة واحدة عبوة 5 مل على 100 ملغ من هيدروكلوريد مونوهيدرات الليدوكائين.</li><li dir="rtl">تحتوي أمبولة واحدة عبوة 10 مل على 200 ملغ من هيدروكلوريد مونوهيدرات الليدوكائين.</li><li dir="rtl">تحتوي أمبولة واحدة عبوة 20 مل على 400 ملغ من هيدروكلوريد مونوهيدرات الليدوكائين.</li></ul><p>المكونات الأخرى هي:&nbsp;</p><ul><li dir="rtl">كلوريد الصوديوم، وهيدروكسيد الصوديوم والماء المخصص للحقن</li></ul>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>Lidocaine Hcl 2% ing هو محلول مخصص للحقن. وهو محلول صاف عديم اللون يحتوي على المكونات المذكورة آنفا مذابة في الماء.</p><ul><li>يتم تقديمه في أمبولات بلاستيكية من البولي إيثيلين تحتوي على 5 مل، أو 10 مل أو 20 مل.</li><li>يتوفر في حزم من 20 أمبولات من كل حجم أو 5 /20/ 5مل</li><li>ويتوفر أيضا في أمبولات زجاجية مصنوعة من الزجاج الشفاف التي تحتوي على 5 مل أيضا.</li><li>يتوفر في حزم من 10 أمبولات عبوة كل منها 5 مل.</li></ul><p>قد لا تُطرح كل أحجام العبوات للتسويق.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="ltr" style="text-align:left">B. Braun Melsungen AG<br />Carl-Braun-Stra&szlig;e 1&nbsp;<br />34212 Melsungen, Germany&nbsp;</p><p dir="ltr" style="text-align:left">&nbsp;<em>Postal address</em><br />34209 Melsungen, Germany</p><p dir="ltr" style="text-align:left">Phone: +49-5661-71-0<br />Fax: +49-5661-71-4567</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            09.2012
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lidocaine HCl 2% inj.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                One ml of the solution for injection contains 20 mg of Lidocaine hydrochloride monohydrate
Accordingly, the contents per ampoule are as follows:
● One Ampoule of 2 ml contains 40 mg of Lidocaine hydrochloride monohydrate
● One Ampoule of 5 ml contains 100 mg of Lidocaine hydrochloride monohydrate
● One Ampoule of 10 ml contains 200 mg of Lidocaine hydrochloride monohydrate
● One Ampoule of 20 ml contains 400 mg of Lidocaine hydrochloride monohydrate

Excipients with known effect:
Sodium (as sodium chloride and sodium hydroxide) 95 μmol/ml

For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection
Clear, colourless aqueous solution
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Local and regional anaesthesia</p><p>Severe symptomatic ventricular tachycardia or tachy-arrhythmia, if assessed to be life-threatening.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><strong>Posology</strong></p><p style="text-align:justify">Local and regional anaesthesia</p><p style="text-align:justify">As a matter of principle the smallest possible dose that produces adequate anaesthesia should be administered.<br />The dosage should be adjusted individually according to the particulars of each case.</p><p style="text-align:justify">Adults<br />When injected into tissues with marked systemic absorption, without combination with a vasoconstrictor, a single dose of lidocaine hydrochloride monohydrate should not exceed 4.5 mg/kg body weight<br />(BW) (or 300 mg). If combined with a vasoconstrictor, 7 mg/kg BW (or 500 mg) of lidocaine hydrochloride monohydrate per single dose should not be exceeded.</p><p style="text-align:justify">For the clinical uses listed below, recommendations for single doses and strengths of the injection solution to be administered to adults with average body weight (70 kg) are as follows:</p><table border="1" cellspacing="1" cellpadding="1" style="width:100%"><tbody><tr><td style="width:122px">Type of anaesthesia</td><td style="width:106px">Concentration [%]</td><td style="width:80px">Usual volume<br />[ml]</td><td style="width:126px">Maximum dose [mg]</td></tr><tr><td style="width:122px">Infiltration=</td><td style="width:106px">0.5-1</td><td style="width:80px">&nbsp;</td><td style="width:126px"><p>300</p><p>500(with epinephrine)</p></td></tr><tr><td style="width:122px">Major nerve blocks</td><td style="width:106px">1-2</td><td style="width:80px">30-50</td><td style="width:126px">500 (with epinephrine)</td></tr><tr><td style="width:122px">Minor nerve blocks</td><td style="width:106px">1</td><td style="width:80px">5-20</td><td style="width:126px">200</td></tr><tr><td style="width:122px">Epidural</td><td style="width:106px">1-2</td><td style="width:80px">15-30*</td><td style="width:126px">500 (with epinephrine)</td></tr><tr><td style="width:122px">Spinal</td><td style="width:106px">1.5 or 5 in 7.5% glucose</td><td style="width:80px">1-2</td><td style="width:126px">100</td></tr><tr><td style="width:122px">Intravenous regional anaesthesia<br />(IVRA)<br />- upper limb<br />-lower limb</td><td style="width:106px"><p>0.5</p><p>0.25</p></td><td style="width:80px"><p>40</p><p>50-100</p></td><td style="width:126px">&nbsp;</td></tr></tbody></table><ul><li>*1.5 ml per segment in average</li></ul><p style="text-align:justify">For prolongation of anaesthesia lidocaine may be combined with a vasoconstrictor, e.g. epinephrine. Addition of epinephrine at a concentration of 1:100 000 to 1:200 000 has proven useful.</p><p style="text-align:justify">Paediatric population</p><p style="text-align:justify">For children, the doses are calculated individually according to the patients&#39;&nbsp;age, body weight and the nature of the procedure. Up to 5mg/kg BW may be administered. With the addition of epinephrine, up to 7 mg/kg can be used. In children with a high body weight a gradual reduction of the dosage is often necessary and should be based on the ideal body weight. Standard textbooks should be consulted for factors affecting specific block techniques and for individual patient requirements. For anaesthesia in children, only a low strength (0.5 % w/v) of the local anaesthetic should be used. To achieve a complete motor block, a higher strength (1 % w/v) may be required.</p><p style="text-align:justify">Lidocaine should be used with caution in children younger than two years of age as there are insufficient data to support the safety and efficacy of this product in this patient population at this time.</p><p style="text-align:justify">Elderly patients</p><p style="text-align:justify">For elderly patients, the doses must be calculated individually according to the patients&#39;&nbsp;age and body weight. Dosages may need adaptation as cardiac output and hepatic blood flow may decrease with advanced<br />age indicating a decreased clearance of lidocaine (see section 5.2).</p><p style="text-align:justify">Other special patient groups</p><ul><li style="text-align: justify;">Doses should be reduced in patients i<strong>n poor general condition</strong> or in those with reduced <strong>protein binding capacity</strong> (resulting e.g. from renal insufficiency, liver insufficiency, cancer, pregnancy).</li><li style="text-align: justify;">In patients with severe <strong>renal insufficiency</strong> the dose may need to be adapted due to reduced clearance and increased half-life of lidocaine (see section 5.2).Patients with <strong>liver diseases show reduced</strong> tolerance towards amide-type local anaesthetics. This may be due to reduced hepatic metabolism and decreased protein synthesis resulting in a lower protein binding rate of the local anaesthetic. Dose reduction is advisable in such cases.</li><li style="text-align: justify;">The dose should be reduced in patients showing clinical signs of <strong>cardiac insufficiency</strong>. Nevertheless, local or regional nerve blockage can be the anaesthetic method of choice in such patients.</li><li style="text-align: justify;">During pregnancy, the dose may need to be reduced depending on the type of anaesthesia. Regional anaesthetic blocks in which usually large doses are required should be avoided during the first trimester. For use in anaesthetic blocks in which smaller doses are administered the dosage may need to be reduced because of the altered anatomical and physiological characteristics in late pregnancy.</li></ul><p style="text-align:justify"><strong>Antiarrhythmic therapy</strong></p><p style="text-align:justify">Adults<br />The dosage must be adjusted according to individual requirements and the therapeutic effect.</p><p style="text-align:justify">Bolus:<br />Usual loading doses are 50-100 mg or 1 . 1.5 mg/kg BW of lidocaine hydrochloride monohydrate as direct intravenous injection, , corresponding to approximately 2.5 - 5 ml or 0.05 - 0.075 ml/kg BW of<br />Lidocaine HCl 2% inj.</p><p style="text-align:justify">The rate of injection should not exceed 25-50 mg/min, corresponding to approximately 1.25 - 2.5 ml/min Lidocaine HCl 2% inj.</p><p style="text-align:justify">If the therapeutic effect of the first dose is insufficient within the first 5 . 10 minutes, the initial dose may be repeated once or twice up to a maximum dose of 200 . 300 mg in 1 hour.</p><p style="text-align:justify"><u>Maintenance:</u><br />To maintain therapeutic plasma lidocaine concentrations (1.5 - 5 micro g/ml), lidocaine hydrochloride monohydrate is infused at a rate of 20 - 50 micro g/kg BW/min (about 1-4 mg/min), corresponding to approximately<br />0.001 . 0.0025 ml/kg BW/min.</p><p style="text-align:justify">Infusions can be prepared by adding 1000 mg of lidocaine hydrochloride monohydrate, corresponding to 50 ml Lidocaine HCl 2% inj., to 500 ml of glucose solution or physiological saline.</p><p style="text-align:justify">The infusion should be terminated as soon as the patient&#39;s basic cardiac rhythm appears to be stable or at the earliest signs of toxicity. It should rarely be necessary to continue the infusion beyond 24 hours.<br />As soon as possible, patients should be changed to an oral antiarrhythmic agent for maintenance therapy.</p><p style="text-align:justify"><u>Paediatric patients</u><br />The safety and the efficacy of the use of lidocaine in children have not yet been definitely established.<br />The dose should be adapted according to the clinical situation and the nature of the procedure.</p><p style="text-align:justify">Infants and children may be given an initial i.v. bolus of 0.5- 1 mg/kg BW. This dose may be repeated<br />according to the response of the patient, but the total dose should not exceed 3-5 mg/kg BW. If required,<br />a maintenance i.v. infusion of 10 - 50 micro g/kg BW/min may be given via an infusion pump.</p><p style="text-align:justify">For advanced cardiovascular life support in children, the recommended dosage is an initial rapid i.v. or intraosseous injection (i.e. bolus) of 1 mg/kg BW up to a maximum initial dose of 100 mg.</p><p style="text-align:justify">If ventricular tachycardia or ventricular fibrillation is not corrected following defibrillation (or<br />cardioversion) and an initial recommended dose of lidocaine, an i.v. or intraosseous infusion should be<br />started at a rate of 20-50 micro g/kg b.w. per min.</p><p style="text-align:justify">Elderly patients<br />For elderly patients, the doses are calculated individually according to the patients&#39;&nbsp;age and body weight. Dosages may need adaptation as cardiac output and hepatic blood flow decrease with advanced age indicating a decreased clearance of lidocaine (see section 5.2).</p><p style="text-align:justify">Other special patient groups<br /><u>Cardiac insufficiency, hepatic insufficiency, co-medication, pregnancy</u> The dose should be reduced in patients with cardiac insufficiency, hepatic insufficiency, in patients receiving drugs that intensify the effects of lidocaine (see section 4.5) and during pregnancy ( see section 4.6). See also section 5.2.</p><p style="text-align:justify"><u>Renal insufficiency</u><br />Renal insufficiency as a rule does not require specific dose adjustment. However, such patients should be monitored for toxic effects caused by accumulation of active metabolites. In cases of severe renal insufficiency the dose may need to be adapted (see also section 5.2).</p><p style="text-align:justify"><strong>Method of administration</strong></p><p style="text-align:justify"><strong>Local and regional anaesthesia</strong></p><p style="text-align:justify">Intradermal, subcutaneous or submucosal use (infiltration), perineural (injection into the surroundings of peripheral nerves), epidural or spinal use. Intravenous use regarding intravenous regional anaesthesia<br />(Bier`s block). Every local anaesthetic procedure should only be carried out by personnel adequately skilled in the respective anaesthetic technique.</p><p style="text-align:justify"><strong>Antiarrhythmic therapy</strong></p><p style="text-align:justify">Intravenous use, intraosseous use.<br />Administer as slow intravenous injection or intravenous infusion after dilution in a suitable vehicle solution.</p><p style="text-align:justify">Because of the relatively short duration of action of lidocaine, the injection should be followed by continuous infusion, if possible, using an infusion pump.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                General
● hypersensitivity towards lidocaine, amide-type local anaesthetics or to any of the excipients listed in section 6.1.

Local and regional anaesthesia
The special contraindications for spinal and epidural anaesthesia must also be observed
● uncorrected hypovolaemia,
● coagulopathy (acquired, induced, genetic),
● increased intracranial pressure,
● intracranial or intraspinal haemorrhage.

Antiarrhythmic therapy
● Severe conduction disorders
● Myocardial infarction within the preceding 3 months
● Markedly decreased cardiac output unless there is life threatening ventricular cardiac arrhythmia
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify"><strong>General</strong></p><p style="text-align:justify">In the case of known allergy towards lidocaine, group allergy towards all amide-type local anaesthetics should be considered.</p><p style="text-align:justify">Lidocaine should only be used with particular caution in patients with liver or kidney diseases or with myasthenia gravis, impaired cardiac conduction (see also section 4.3), cardiac insufficiency, bradycardia, impaired respiratory function and severe shock. See also section 4.2.</p><p style="text-align:justify">In general, prior to injection of lidocaine, it must be made sure that all equipment for resuscitation and emergency medication for the treatment of toxic reactions are instantly available.</p><p style="text-align:justify">Patients with <strong>epilepsy</strong> should be carefully monitored for the occurrence of central nervous symptoms. An increased tendency to convulsions should be considered even with doses below maximum.</p><p style="text-align:justify"><strong>Local and regional anaesthesia</strong></p><p style="text-align:justify">Sudden arterial hypotension may occur as a complication of spinal and epidural anaesthesia, in particular in elderly patients.<br />Particular caution should also be exercised if the local anaesthetic is to be injected into inflamed (infected) tissue because of increased systemic absorption due to higher blood flow and decreased effect due to the lower pH of infected tissue.</p><p style="text-align:justify">A risk of post-spinal headache is associated with spinal anaesthesia mainly in adolescents and in adults up to the age of 30 years. This risk of post-spinal headache can be markedly reduced by choosing sufficiently thin injection cannulae.</p><p style="text-align:justify">After removing the tourniquet after intravenous regional anaesthesia there is an increased risk of adverse effects. Therefore the local anaesthetic should be drained off in several portions.</p><p style="text-align:justify">During anaesthetic procedures in the neck and head region patients are at increased risk of central nervous toxic effects of the drug. See also section 4.8.</p><p style="text-align:justify"><strong>Antiarrhythmic therapy</strong></p><p style="text-align:justify">In acidosis, the plasma protein binding of lidocaine is reduced and therefore the concentration of free<br />lidocaine is increased. Hence the effect of lidocaine may be intensified in acidosis.</p><p style="text-align:justify">Hypokalaemia, hypoxia, and disorders of acid-base balance need to be corrected prior lidocaine is<br />used in patients who require large doses of antiarrhythmic agents.</p><p style="text-align:justify">During prolonged parenteral therapy with lidocaine, fluid balance, serum electrolytes and acid-base<br />balance should be monitored regularly.</p><p style="text-align:justify">Administration of lidocaine should be accompanied by continuous monitoring of ECG, blood pressure,<br />state of consciousness and respiration. Especially adjustment of the dose of the anti-arrhythmic drug<br />requires careful cardiological monitoring. Cardiological emergency equipment must be available. If<br />one or more parameters indicate worsening of cardiac function, revision of therapy, which may include<br />discontinuation of lidocaine, is necessary.</p><p style="text-align:justify"><strong>Note:</strong><br />In narcotised patients central nervous disorders may remain unrecognised and cardiac adverse effects<br />may suddenly occur without other previous warning symptoms.</p><p style="text-align:justify"><strong>Special warnings/precautions regarding excipients</strong><br />5 ml and 10 ml ampoule:<br />This medicinal product contains sodium, but less than 1 mmol (23 mg) per ampoule, i.e. it is &lsquo;essentially sodium free&rsquo;.</p><p style="text-align:justify">20 ml ampoule:<br />This medicinal product contains 1.9 mmol (43.7 mg) sodium per 20 ml ampoule. To be taken into consideration for patients on a controlled sodium diet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacodynamic interactions</strong></p><p><br />● Vasoconstrictors</p><p>The local anaesthetic effect is prolonged by combination with a vasoconstrictor, e.g. epinephrine.<br />If lidocaine is given as antiarrhythmic agent, additional medication with epinephrine or norepinephrine<br />may lead to potentiation of the cardiac side effects.</p><p><br />● Sedatives, hypnotics<br />Lidocaine should be administered with due caution to patients receiving medication with sedatives<br />that also affect the function of the CNS and therefore may alter the toxicity of lidocaine.<br />There may be an additive effect between the local anaesthetic effect and sedatives or hypnotics.</p><p><br />● Muscle relaxants<br />The effect of muscle relaxants is prolonged by lidocaine.</p><p><br />● Combination with other local anaesthetics<br />Combination of different local anaesthetics may lead to additive effects on the cardiovascular and<br />the central nervous system.</p><p><br />● Volatile anaesthetics<br />If lidocaine and volatile anaesthetics are given simultaneously, the depressive effects of both may<br />be intensified.</p><p><br />● Class I antiarrhythmic agents<br />Simultaneous administration of lidocaine and other class I antiarrhythmic agents should be<br />avoided because of the risk that serious cardiac adverse effects occur.</p><p><br />● Other anti-arrhythmic agents<br />If lidocaine is combined with other antiarrhythmic agents such as beta receptor blockers or calcium<br />channel blockers, the inhibitory effect on atrioventricular and intraventricular conduction and<br />on contractility may be enhanced.</p><p><br />● Medicinal products that can lower the seizure threshold<br />As lidocaine itself may reduce the seizure threshold co-administration with other medicinal products<br />lowering the seizure threshold (e.g. tramadol or bupropion) may increase the risk of seizures.</p><p>&nbsp;</p><p><strong>Pharmacokinetic interactions</strong></p><p><br />● Medicinal products that alter the hepatic blood flow, cardiac output or peripheral distribution<br />of lidocaine may influence plasma levels of lidocaine</p><p><br />● Beta receptor blockers, vasoconstrictors, cimetidine<br />Beta receptor blockers (e. g. propranolol, metoprolol see also below, metoprolol), cimetidine<br />(see also below), and vasoconstrictors like norepinephrine reduce cardiac output and/or hepatic<br />blood flow and therefore reduce the plasma clearance of lidocaine prolonging its elimination<br />half life. Therefore, due account should be taken of the possibility of accumulation of lidocaine.</p><p><br />● As lidocaine is mainly metabolized via CYP 3A4 and CYP 1A2 Concurrently administered drug<br />substances that are substrates, inhibitors or inducers of hepatic enzymes, isoenzyme CYP3A4<br />and CYP1A2, may have an influence on the pharmacokinetics of lidocaine and thus also on its<br />effect.</p><p><strong>Inhibitors of CYP 3A4 and/or CYP 1A2</strong><br />Concurrent administration of lidocaine with inhibitors of CYP3A4 and/or CYP1A2 may lead to<br />accelerated plasma concentrations of lidocaine. Increased plasma levels have been reported for<br />e.g. erythromycine, fluvoxamine, amiodarone, cimetidine, protease inhibitors.</p><p><strong>Inducers of CYP 3A4 and/or CYP 1A2</strong><br />Drugs inducing CYP3A4 and/or CYP 1A2, e.g. barbiturates (mainly phenobarbital), carbamazepine,<br />phenytoin or primidone, accelerate the plasmatic clearance of lidocaine and thus reduce<br />the efficacy of lidocaine.</p><p><strong>Substrates of CYP 3A4 and/or CYP 1A2</strong><br />Co-administration with other substrates of CYP 3A4 and/or CYP 1A2 may lead to increased<br />plasma levels of the drugs (e.g. propranolol).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p><br />There are no or a limited amount of data from the use of lidocaine in pregnant women. Animal studies<br />do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see 5.3).</p><p>However, lidocaine rapidly crosses the placenta. Therefore high plasma concentrations of lidocaine in<br />the mother`s plasma may cause central nervous depression, alteration of the peripheral vascular tone<br />and cardiac function in the fetus/neonate.</p><p>Lidocaine should only be used in pregnancy if there is an imperative indication. Then doses should be<br />as low as possible.</p><p><strong>Local and regional anaesthesia</strong><br />Use of lidocaine for epidural, pudendal, caudal or paracervical block may cause varying degrees of<br />foetal and neonatal toxicity (e.g. bradycardia, hypotonia or respiratory depression). An accidental subcutaneous<br />injection of lidocaine in the fetus during paracervical or perineal block may cause apnoea, hypotension and convulsive fits and may thus put the new-born at vital risk.</p><p>In general lidocaine in strengths of 10 mg/ml should be preferred during pregnancy.</p><p><strong>Breastfeeding</strong><br />Lidocaine/metabolites are excreted in small amounts into human milk, but at therapeutic doses of<br />Lidocaine HCl 2% inj. no effects on the breastfed newborns/infants are anticipated.</p><p><strong>Fertility</strong><br />No data available</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In General Lidocaine HCl 2% inj. has negligible influence on the ability to drive and use machines.<br />When using this medicinal product, the doctor has to asses in each individual case whether a patient is<br />able to take part in traffic or to operate machinery. However, when outpatient anaesthesia affects areas<br />of the body involved in driving or operating machinery, patients should be advised to avoid these activities<br />until normal function is fully restored.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>General</strong></p><p><br />The frequency and severity of the undesirable effects of lidocaine depend upon the dose, the method of<br />administration and the patient&lsquo;s individual sensitivity.</p><p>Symptoms of local toxicity may occur after the administration of lidocaine. Systemic adverse effects<br />may be expected at plasma concentrations of lidocaine exceeding 5-10 mg/l. They become manifest in<br />the form of both CNS symptoms and cardiovascular symptoms (see also section 4.9).</p><p>Considering the method of administration systemic undesirable effects are more frequently associated<br />with the use of lidocaine as antiarrhythmic agent.</p><p>The possible undesirable effects after administration of lidocaine as local anaesthetic are largely the<br />same as those produced by other amide-type local anaesthetics.</p><p>Undesirable effects are listed according to their frequencies as follows:<br />Very Common<br />(&ge; 1/10)<br />Common: &ge; 1/100 to &lt; 1/10<br />Uncommon ( 1/1 000 to &lt; 1/100)<br />Rare: (&ge; 1/10 000 to &lt; 1/1 000)<br />Very rare (&lt; 1/10 000)<br />Not known: (cannot be estimated from the available data)</p><p><strong>Local and regional anaesthesia</strong></p><p>Immune system disorders<br /><u>Rare:</u> Anaphylactic reactions manifesting as urticaria, oedema, bronchospasm, respiratory<br />distress and circulatory symptoms up to anaphylactic shock.</p><p><strong>Nervous system disorders</strong><br /><u>Common:</u> Transient neurological symptoms especially pain after spinal andepidural anaesthesia<br />(up to 5 days). Rare: Neurological complications following central nervous<br />blocks &ndash; mainly spinal anaesthesia &ndash; such as persistent anaesthesia, paraesthesia,<br />paresis up to paraplegia,Cauda equina syndrome (i.e. bilateral leg weakness<br />up to paraplegia, saddle anaesthesia, urinary retention and fecal incontinence),,<br />headache accompanied by tinnitus and photophobia.</p><p>Cranial nerve lesions, neurosensory deafness (if administered in head and neck<br />regions)</p><p>Horner&rsquo;s syndrome, associated with epidural anaesthesia or regional applications<br />in the head/neck region.</p><p><strong>Gastrointestinal disorder</strong><br /><u>Very common: </u>Nausea, vomiting</p><p><strong>Injury, poisoning and procedural complications</strong><br />Rare: Trauma, transient radicular irritation due to spinal anaesthesia, compression of<br />the spinal cord after development of haematoma<br />General disorders and administration site conditions<br />Rare: Shivering (after epidural use)</p><p><strong>Antiarrhythmic therapy</strong><br />The most frequently seen undesirable effects after administration of lidocaine as antiarrhythmic agent<br />are those on the nervous system. Further heart function and circulation may be affected. Most of the<br />reactions observed are associated with high injection speed or infusion rate.</p><p><strong>Immune system disorders</strong><br />Rare: Anaphylactic reactions manifesting as urticaria, oedema, bronchospasm, respiratory<br />distress and circulatory symptoms up to anaphylactic shock.</p><p><strong>Psychiatric disorders</strong><br />Common: Confusion, restlessness, irritability, euphoria, hallucinations and depression.<br />Very common: Dysphoria,</p><p><strong>Nervous system disorders</strong><br />Common: Somnolence, dizziness, vertigo, dysarthria, tinnitus, trembling, tingling and paraesthesia<br />(skin), blurred vision,<br />Rare: Muscular twitching, up to generalised convulsions, depressed level of consciousness<br />up to coma.</p><p><strong>Cardiac disorders</strong><br />Rare: Bradycardia, atrioventricular block up to cardiac arrest<br />Very rare: Ventricular tachycardia</p><p><strong>Vascular disorders</strong><br />Rare: Hypotension</p><p><strong>Gastrointestinal disorders</strong><br />Very common: Nausea, vomiting, dysphagia,</p><p><strong>Respiratory, thoracic and mediastinal disorders</strong><br />Rare: Respiratory depression or even arrest.</p><p><strong>Paediatric poulation</strong><br />Frequency, type and severity of adverse reactions in children are expected to be the same as in adults.</p><p><strong>Elderly patients</strong><br />In elderly patients the incidence of undesirable effects may be increased (see section 4.4).</p><p><strong>To report any side effects:<br />National Pharmacovigilance &amp; Drug Safety Center (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340<br />Toll free phone : 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The toxic effects of lidocaine depend on the level of the plasma concentration; the higher the plasma<br />concentration and the more rapid its rise, the more frequent and more serious are the toxic reactions.</p><p>Depending on the individual sensitivity, toxic reactions occur from a concentration of approximately 5<br />- 9 mg lidocaine per litre upward in venous blood.</p><p>The lethal plasma concentration for humans is in the range 6 to 33 mg lidocaine per litre.</p><p><strong>Symptoms</strong><br />&nbsp;</p><p><strong>Effects on the CNS:</strong></p><p>Low toxic overdoses of lidocaine result in stimulation of CNS.</p><p>Gross overdose, producing high toxic plasma concentrations, causes depression of the central functions.</p><p>Two phases of lidocaine intoxication can be distinguished:</p><p>Stimulation<br />At the beginning of intoxication with lidocaine patients mainly show symptoms of excitation: unrest,<br />vertigo, disturbances of hearing and vision, unpleasant perioral sensations,<br />agitation, hallucination, euphoria, paraesthesias (e.g. circumoral<br />paraesthesia and numbness of the tongue), dizziness, tinnitus, blurred<br />vsions, nausea, vomiting, dysarthria. Shivering and muscular twitching<br />may be signs of imminent attacks of generalized convulsion.<br />Subconvulsive plasma levels of lidocaine often also lead to sleepiness<br />and sedation. Tachycardia, hypertension and flushing may occur as a sign<br />of initial stimulation of the sympathetic nervous system.</p><p>Depression<br />During progress of the intoxication of the CNS increasing impairment of the brain stem functions appears<br />in the form of respiratory depression and coma, even up to death.</p><p><strong>Effects on cardiovascular circulation:</strong></p><p>Unpalpable pulse, pallor, hypotension, bradycardia, arrhythmias, cardiovascular collapse, ventricular<br />fibrillation, cardiac arrest.</p><p>Sudden hypotension often is the first sign of cardiovascular toxicity of lidocaine. The hypotension is<br />mainly caused by the reduction or block of cardiac impulse conduction. These toxic effects, however,<br />are less relevant than those on the CNS.</p><p><strong>Treatment<br />The occurrence of central nervous or cardiovascular symptoms demands the following emergency treatment:</strong><br />● Immediately discontinue administration!<br />● Ensure patency of the airways.<br />● Supply additional oxygen. If necessary provide artificial ventilation with pure oxygen &ndash; assisted<br />or controlled &ndash; initially via mask and air bag, then intubate. The oxygen therapy must be continued<br />until all vital functions have returned to normal.<br />● Monitor blood pressure, pulse and pupil width carefully.<br />● Maintain the circulation by sufficient supply of intravenous fluid.<br />● Immediately start cardio-pulmonary resuscitation, if necessary.</p><p>These measures are also applicable in the case of accidental total spinal anaesthesia, first manifesting<br />as unrest, whispering voice, and sleepiness. The latter can proceed to unconsciousness and respiratory<br />arrest.</p><p>Further therapeutic measures include the following:</p><p>Acute life-threatening hypotension should be treated with intravenous vasopressors. Bradycardia<br />caused by increased vagal tone should be treated with intravenous atropine. Convulsions not reacting<br />to sufficient oxygenation should be treated with intravenous benzodiazepins or ultra-short-acting barbiturates.</p><p>Centrally acting analeptics are contra-indicated.</p><p>There is no specific antidote.</p><p>Lidocaine cannot be eliminated by haemodialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group</strong><br />Anaesthetics, local, amides: ATC code: N01B B02</p><p>Antiarrhythmics, class Ib: ATC code: C01BB01</p><p><strong>Mechanism of action</strong><br />&nbsp;</p><p><strong>Local and regional anaesthesia</strong></p><p>Lidocaine is a local anaesthetic agent of the amide type.</p><p>Lidocaine reduces the permeability of cell membranes for cations, in particular sodium ions, at higher<br />concentrations also for potassium ions. This leads, depending on the concentration of lidocaine, to reduced<br />excitability of the nerve fibres because the increase of sodium permeability producing the action<br />potential is slowed down. From inside the cell the lidocaine molecule enters the open sodium channel<br />and blocks it by binding to a specific receptor. A direct effect of incorporation of lidocaine in the cell<br />membrane is much less relevant.</p><p>Because lidocaine, before reaching its site of action, must pass into the cell, its effect depends on its<br />pKa and on the environmental pH, i.e. on the proportion of the free base which is the moiety predominantly<br />migrating through the lipophilic membranes of nerve fibres.</p><p>In inflamed tissue the local anaesthetic effect is reduced due to the lower pH in such regions.</p><p><strong>Antiarrhythmic therapy</strong><br />In membranes of myocardial fibres lidocaine inhibits the large transient increase in the permeability of<br />the membrane for sodium channels during the plateau of the action potential and increases the potassium<br />efflux during repolarisation period.</p><p>In PURKINYE fibres the duration of action potentials and their effective refractory time are shortened<br />while impulse conduction is slowed down.</p><p>Impulse conduction in the sinus node and supraventricular regions remains virtually unaffected.</p><p><strong>Clinical efficacy and safety</strong><br />&nbsp;</p><p><strong>Local and regional anaesthesia</strong><br />Lidocaine inhibits the function of excitable structures such as sensor, motor and autonomic nerve fibres<br />and the cardiac impulse conducting system. Lidocaine reversibly inhibits the conduction in sensitive<br />nerve fibres in the area of application. The order of loss of nerve function is as follows: pain, temperature,<br />touch, and pressure.</p><p>The local anaesthetic effect of lidocaine lasts for about 30 minutes- 3 hours depending on the type of<br />anaesthesia.</p><p><strong>Antiarrhythmic therapy</strong><br />In the myocardium the excitation and fibrillation thresholds are raised.<br />Lidocaine suppresses heterotopic pacemakers and action potentials originating from delayed potentials<br />and tachyarrhythmias caused by circus rhythm.</p><p>The sodium channels more avidly bind lidocaine when the membrane is depolarized. Therefore the<br />antiarrhythmic effect of lidocaine is particularly marked in cases of increased excitation frequency</p><p>The effect of lidocaine is enhanced if the resting potential is less negative, e.g. in hyperkalaemia<br />and/or myocardial ischaemia. In situations of hyperpolarisation, e.g. due to hypokalaemia, the effect of<br />lidocaine is reduced.</p><p>Lidocaine has been shown to eliminate re-entrant ventricular arrhythmias in the late myocardial phase<br />by further depression and blocking of conduction in the re-entrant pathway.</p><p>Therapeutic plasma concentrations should lie between 1.5 and 5 mg/l. Beyond 5 mg/l, toxic effects on<br />the CNS and the cardiovascular system are to be expected.</p><p><strong>Other pharmacological effects</strong><br />Lidocaine shows weak parasympatholytic activity.</p><p>Intradermally administered lidocaine acts at low concentrations as a mild vasoconstrictor and at higher<br />concentrations as vasodilator.</p><p><strong>Antiarrhythmic therapy</strong><br />The effects of lidocaine on myocardial contractility, blood pressure, cardiac output and heart rate are<br />very small.</p><p>Patients with impaired function of the sinus node, however, may respond particularly markedly to the<br />conduction suppressing effect of lidocaine.</p><p>In the period immediately following myocardial infarction the coronary blood flow may be increased<br />by lidocaine.</p><p><strong>Paediatric population</strong><br />There are no data indicating that the pharmacodynamic properties of lidocaine in children should be different from those established for adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong></p><p>Plasma levels depend on the site and mode of administration. However, there is a poor relationship between<br />the amount of local anaesthetic injected and peak plasma levels. After intravenous administration<br />the bio-availability is 100 %.</p><p>Maximum concentrations are achieved within latest 30 minutes, in the majority of patients maximum<br />concentrations are met within 10-20 minutes.</p><p>After i<strong>ntramuscular injection</strong> of 400 mg of lidocaine hydrochloride monohydrate for intercostal block<br />the maximum plasma concentration (Cmax) has been determined to be 6.48 mg/l, attained after 5 &ndash; 15<br />min (tmax).</p><p>After i<strong>ntravenous administration</strong>, onset of the therapeutic effect of lidocaine is rapid. Therapeutic<br />plasma concentrations are reached within 1 - 2 min. The effect of a bolus injection lasts for 10 -<br />20 min; in order to maintain the therapeutic effect of lidocaine, its administration must be continued in<br />the form of an intravenous infusion.</p><p>After <strong>continuous infusion</strong> and when no loading dose is given the steady state of plasma concentration<br />was achieved not earlier than 5 hours (range, 5 &ndash; 10 hours) of beginning of the infusion. However,<br />therapeutic concentrations had already been achieved after 30 &ndash; 60 min.</p><p>After <strong>subcutaneous administration, </strong>Cmax values reached 4.91 mg/l (vaginal injection) or 1.95 mg/l<br />(abdominal injection), respectively. In a study involving 5 healthy volunteers, after maxillar-buccal infiltration<br />anaesthesia with 36 mg of lidocaine hydrochloride monohydrate, using a 2 % solution, the<br />Cmax value reached 0.31 mg/l.</p><p>After <strong>epidural injection </strong>the measured maximum plasma concentrations do not seem to be directly<br />proportional to the dose applied. Administration of 400 mg resulted in Cmax values of 3 - 4 mg/l.<br />No data are available on pharmacokinetics after intrathecal administration.</p><p><strong>Distribution</strong><br />Lidocaine follows a biphasic elimination kinetic. After intravenous administration the drug substance<br />is first rapidly distributed from the central compartment into intensively perfused tissues and organs<br />(-distribution phase). This phase is followed by redistribution into skeletal muscles and adipose tissue.<br />The half life time during the -distribution phase is approximately 4-8 minutes. Distribution into<br />peripheral tissues is predicted to occur within 15 min.</p><p>The plasma protein binding rate is approximately 60 &ndash; 80 per cent in adults. It is dependant on the<br />drug concentration and additionally on the concentration of the -1-acid glycoprotein (AAG). The<br />AAG is an acute phase protein that is binding free lidocaine and may be increased e.g. after trauma,<br />surgery or burns depending on the pathophysiological condition of the patient. To the contrary it had<br />been shown that AAG concentrations are low in neonates and patients suffering from liver impairment<br />leading to a marked reduction of lidocaine plasma protein binding.</p><p>The distribution volume may be altered in patients suffering from further diseases, e.g. heart insufficiency,<br />liver insufficiency or renal insufficiency.</p><p><strong>Biotransformation</strong><br />Besides distribution of Lidocaine in other compartments (e.g. cerebrospinal fluid), the drug is rapidly<br />metabolised in the liver by mono-oxygenases mainly via oxidative desalkylation, hydroxylation at the<br />aromatic ring and hydrolysis of the amide bond. Hydroxylated derivatives undergo conjugation. In total,<br />approximately 90 % of lidocaine are metabolised to 4-hydroxy-2,6-xylidine, to 4-hydroxy-2,6-<br />xylidine glucuronide and to a lower degree to the active metabolites monoethyl glycine xylidide<br />(MEGX) and glycine xylidide (GX). The latter may accumulate during longer lasting infusions or in<br />the presence of severe renal insufficiency due to their longer half life time as compared to lidocaine itself.<br />In the presence of liver diseases the metabolic rate may be reduced to 10 &ndash; 50 per cent of normal.</p><p>Results with human liver microsomes and recombinant human CYP isoforms demonstrated that<br />CYP1A2 and CYP3A4 enzymes are the major CYP isoforms involved in lidocaine N-deethylation.</p><p>The hepatic blood flow appears to limit the rate of lidocaine metabolism. As a consequence the plasma<br />t1/2 of lidocaine and its metabolites may be prolonged and significant effects on pharmacokinetics and<br />dosage requirements of lidocaine are to be expected in patients with impaired liver perfusion, e.g. after<br />acute myocardial infarction, in the presence of cardiac insufficiency, liver disease or congestive heart failure.</p><p><strong>Elimination</strong><br />Less than &ndash;10 per cent of lidocaine are excreted unchanged in urine, the remaining proportion in the<br />form of the metabolites.</p><p>The elimination half-life is 1.5 &ndash; 2 hours in healthy adults and approximately 3 hours in newborns.<br />The half-lives of the active metabolites MEGX and GX are about 2-6 hours and 10 hours, respectively.<br />Since their plasma t1/2 are longer than that of lidocaine, accumulation of metabolites, particularly GX,<br />may occur during prolonged infusion.</p><p>Additionally, the elimination rate depends on the pH; it can be increased by acidification of the urine.<br />The plasma clearance is about 0.95 l/min.</p><p><strong>Paediatric population</strong><br />After epidural anaesthesia of the mother, the elimination half-life time in the new-born was approximately<br />3 hours; after infiltration of the perineum and after paracervical block lidocaine was found in<br />the urine of the new-born during 48 hours following anaesthesia.</p><p>The plasma t1/2 is increased 2-3 fold in neonates, due to a slower rate of metabolism and in parts to the<br />expanded distribution volume. Absorption and elimination may be faster in children than adults, although<br />other studies suggested that differences in pharmacokinetics (between children and adults) decrease<br />by correcting for BW.</p><p><strong>Pharmacokinetics in special clinical situations</strong><br />● In the presence of renal insufficiency the plasma half-life time of lidocaine seemed to be unaltered<br />except for some accumulation of GX during infusion of 12 hours or more. This accumulation<br />seemed to be associated with long-term administration of the drug. However in patients<br />with severe renal insufficiency clearance of lidocaine was approximately halved and half-life<br />time of lidocaine was about twice the amount than in healthy patients. Elimination half-life and<br />volume of distribution may appear to be prolonged resp. increased in the elderly due to reduced<br />cardiac output and/or hepatic blood flow.</p><p><strong>Pregnancy and lactation</strong><br />Lidocaine passes across the placental barrier by simple diffusion and reaches the fetus within a few<br />minutes of administration. After epidural administration, the fetal to maternal plasma concentration ratio is 0.5 &ndash; 0.7.</p><p>After infiltration of the perineum and after paracervical block, markedly higher concentrations of<br />lidocaine have been found in umbilical blood.</p><p>The fetus is able to metabolise lidocaine. The levels in fetal blood are approximately 60% of the concentrations<br />in the maternal blood. Due to a lower plasma protein binding in fetal blood, the concentration<br />of the pharmacologically active free lidocaine is 1.4 fold the maternal concentration</p><p>Lidocaine is secreted into breast milk only in small amounts.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology,<br />repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction and development.</p><p><strong>Single-dose toxicity</strong><br />Numerous studies on acute toxicity of lidocaine have been carried out in various animal species. Toxicity<br />manifested in the form of CNS symptoms. These included also convulsions with lethal outcome.</p><p>In man, toxic plasma lidocaine concentrations leading to cardiovascular or central nervous symptoms<br />have been reported to be in the range of 5 &ndash; 10 mg/l</p><p><strong>Mutagenic and tumorigenic potential</strong><br />Mutagenicity studies with lidocaine showed negative results. However, there are findings indicating<br />that a metabolite of lidocaine, 2,6-xylidine, appearing in rats and possibly also in man, might be mutagenic.<br />The mutagenic effect was shown in in-vitro tests applying very high, nearly toxic doses of the metabolite.</p><p>At present there are no indications of a mutagenic effect of lidocaine itself.</p><p>In a carcinogenicity study with transplacental exposure of rats to 2,6-xylidine and subsequent treatment<br />with the same substance for 2 years a tumorigenic potential was shown. This highly sensitive test<br />demonstrated the incidence of benign and malignant tumors in the nasal cavity (ethmoturbinalia).</p><p>A relevance of these findings for humans cannot be definitely ruled out, therefore high-dose administration<br />over long periods should be avoided.</p><p><strong>Reproduction toxicity</strong><br />Investigations of reproduction toxicity did not reveal embryotoxic or teratogenic effects. Only a reduction<br />of fetal weight has been observed.</p><p>When administered to pregnant rats at doses almost as high as the therapeutic maximum doses applied<br />in man, neurological behavioural deviations in the offspring had been seen.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium chloride,<br />sodium hydroxide,<br />water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lidocaine HCl 2% inj. is incompatible with solutions containing sodium bicarbonate and other alkaline solutions. It must therefore not be mixed with those.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened
 Glass ampoules 3 years
 Polyethylene ampoules of 5 ml: 2 years
 Polyethylene ampoules of 10 and 20 ml: 3 years
After first opening
Containers once opened must not be stored for later use (see section 6.6). The solution is to be administered
immediately after opening the container.
After dilution
From a microbiological point of view, the product should be used immediately after dilution. If not
used immediately, in-use storage times and conditions prior to use are the responsibility of the user.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25C.<br />For storage conditions of the diluted medicinal product, see section 6.3.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lidocaine HCl 2% inj. is supplied in</p><ul><li>Ampoules of colourless glass type I (Ph. Eur.), contents: 5 ml, available in packs of:10 ~ 5 ml</li><li>Ampoules of low-density polyethylene contents: 5 ml, 10 ml and 20 ml available in packs of :<ul><li>20 ~ 5 ml</li><li>20 ~ 10 ml</li><li>20 ~ 20 ml</li><li>and 5 X 20 X&nbsp;5 ml.</li></ul></li><li>Not all pack sizes may be marketed.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements for disposal.</p><p>Only to be used if the solution is clear and colourless and the container and its closure are undamaged.<br />Containers are for single use only. Discard container and any unused content after use.html&gt;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                B. Braun Melsungen AG
Carl-Braun-Str 1
34212 Melsungen, Germany

Postal address
34209 Melsungen, Germany

Phone: +49 5661 71 0
Fax +49 5661 71 4567r
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                09.2012
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>